Evaluation of the Relationships between Irisin Levels and Cognitive Functions in Individuals with Schizophrenia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Irisin is a myokine that is involved in neurogenesis, neuronal proliferation, and neuronal differentiation. Many research examine the relationship between irisin and schizophrenia. In this study, we aimed to evaluate the relationship between irisin levels and cognitive functions in individuals with schizophrenia. Methods: Ninety-six individuals who were diagnosed with schizophrenia were included. The Brief Psychiatric Rating Scale (BPRS) was used to assess disease severity. To evaluate the cognitive functions of the patients, the trail-making test was evaluated with the A and B forms and the verbal memory processes scale. After a 12-hour night fast, samples of fasting blood were obtained from the participants. Results: There was no significant correlation between irisin, duration of disease, and BPRS total score. In the analysis performed, a positive correlation was found between the plasma irisin level and the error score of the trail-making test form B. Other than that, no correlation was found between irisin level and cognitive performance in schizophrenia patients. In addition, in subgroup analysis between genders, it was determined that the duration of the trail-making test B was longer in female schizophrenia patients. Conclusion: In this study, there was a positive correlation between the trail-making test B-form error scores and the irisin levels. This relationship between impaired executive functions and irisin levels may suggest that the irisin level is increased as compensation for the impairment in executive functions. More research is needed to understand the role of irisin in cognitive impairment and schizophrenia.
Abstract
Objective: Irisin is a myokine that is involved in neurogenesis, neuronal proliferation, and neuronal differentiation. Many research examine the relationship between irisin and schizophrenia. In this study, we aimed to evaluate the relationship between irisin levels and cognitive functions in individuals with schizophrenia. Methods: Ninety-six individuals who were diagnosed with schizophrenia were included. The Brief Psychiatric Rating Scale (BPRS) was used to assess disease severity. To evaluate the cognitive functions of the patients, the trail-making test was evaluated with the A and B forms and the verbal memory processes scale. After a 12-hour night fast, samples of fasting blood were obtained from the participants. Results: There was no significant correlation between irisin, duration of disease, and BPRS total score. In the analysis performed, a positive correlation was found between the plasma irisin level and the error score of the trail-making test form B. Other than that, no correlation was found between irisin level and cognitive performance in schizophrenia patients. In addition, in subgroup analysis between genders, it was determined that the duration of the trail-making test B was longer in female schizophrenia patients. Conclusion: In this study, there was a positive correlation between the trail-making test B-form error scores and the irisin levels. This relationship between impaired executive functions and irisin levels may suggest that the irisin level is increased as compensation for the impairment in executive functions. More research is needed to understand the role of irisin in cognitive impairment and schizophrenia.
참고문헌 (43)
- Boström P, "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis", Nature, 481, pp.463~468 (2012)
- Cheng A, "Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines", Nat Commun, 3, pp.1250~ (2012)
- Chen N, "Irisin, an exercise-induced myokine as a metabolic regulator : An updated narrative review", Diabetes Metab Res Rev, 32, pp.51~59 (2016)
- Dun SL, "Irisin-immunoreactivity in neural and non-neural cells of the rodent", Neuroscience, 240, pp.155~162 (2013)
- Wrann CD, "Exercise induces hippocampal BDNF through a PGC-1α", FNDC5 pathway, 2013, pp.18, 649~659
- Hashemi MS, "Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells", Neuroscience, 231, pp.296~304 (2013)
- Lourenco MV, "Exercise-linked FNDC5", irisin rescues synaptic plasticity and memory defects in Alzheimer’s models, 2019, pp.25, 165~175
- Zsuga J, "FNDC5", irisin, a molecular target for boosting reward-related learning and motivation, 2016, pp.90, 23~28
- Zsuga J, "‘Proactive’ use of cue-context congruence for building reinforcement learning’s reward function", BMC Neurosci, 17, pp.70~ (2016)
- Adarsh Tripathi, "Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies", Clinical Psychopharmacology and Neuroscience, 16(1), pp.7~17 (2018), 대한정신약물학회[DOI]
- Li DJ, "The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1", 2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia, 2017, pp.68, 31~42
- Moon HS, "Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines", Metabolism, 62, pp.1131~1136 (2013)
- Peng J, "Irisin protects against neuronal injury induced by oxygenglucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway", Mol Immunol, 91, pp.185~194 (2017)
- Zhang W, "Irisin : A myokine with locomotor activity", Neurosci Lett, 595, pp.7~11 (2015)
- Gamze Erzin, "Could Irisin Levels be Affected by Physical Activity in Patients with Schizophrenia?", Clinical Psychopharmacology and Neuroscience, 19(4), pp.677~682 (2021), 대한정신약물학회[DOI]
- Overall JE, "The brief psychiatric rating scale", Psychol Rep, 10, pp.799~812 (1962)
- Soykan C, "Institutional differences and case typicality as related to diagnosis system severity, prognosis and treatment, in psychology", Master, pp.1989
- Bowie CR, "Administration and interpretation of the Trail Making Test", Nat Protoc, 1, pp.2277~2281 (2006)
- Türkeş N, "A study to determine the norms for the trail making test for the age range of 20-49 in Turkey", Turk Psikiyatri Derg, 26, pp.189~196 (2015)
- Öktem Ö, "Öktem verbal memory processes test (ÖKTEM SBST)handbook" (2011), Turkish Psychologists Association Publications
- Öktem Ö, "A verbal test of memory processes a preliminary study", Noro Psikiyatr Ars, 29, pp.196~206 (1992)
- Sharma T, "Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment", Psychiatr Clin North Am, 26, pp.25~40 (2003)
- Bowie CR, "Cognitive deficits and functional outcome in schizophrenia", Neuropsychiatr Dis Treat, 2, pp.531~536 (2006)
- Kennard JA, "A comparison of low-and high-impact forced exercise : Effects of training paradigm on learning and memory", Physiol Behav, 106, pp.423~427 (2012)
- Phillips C, "Neuroprotective effects of physical activity on the brain : A closer look at trophic factor signaling", Front Cell Neurosci, 8, pp.170~ (2014)
- Heyn P, "The effects of exercise training on elderly persons with cognitive impairment and dementia : A meta-analysis", Arch Phys Med Rehabil, 85, pp.1694~1704 (2004)
- Smith JC, "Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders", Neuroimage, 54, pp.635~644 (2011)
- Wang K, "Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice", Mediators Inflamm, 2019, pp.1567179~ (2019)
- Wrann CD, "FNDC5", irisin-their role in the nervous system and as a mediator for beneficial effects of exercise on the brain, 2015, pp.1, 55~61
- Belviranli M, "The relationship between brain-derived neurotrophic factor, irisin and cognitive skills of endurance athletes", Phys Sportsmed, 44, pp.290~296 (2016)
- Lourenco MV, "Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer’s disease", Alzheimers Dement(Amst), 12, pp.e12034~ (2020)
- Szuhany KL, "A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor", J Psychiatr Res, 60, pp.56~64 (2015)
- Lezak MD, "Neuropsychological assessment" (1995), Oxford University Press
- Green MF, "What are the functional consequences of neurocognitive deficits in schizophrenia?", Am J Psychiatry, 153, pp.321~330 (1996)
- Green MF, "Neurocognitive deficits and functional outcome in schizophrenia : are we measuring the"right stuff"?", Schizophr Bull, 26, pp.119~136 (2000)
- Hoff AL, "Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia", Am J Psychiatry, 156, pp.1336~1341 (1999)
- Mohamed S, "Generalized cognitive deficits in schizophrenia : A study of first-episode patients", Arch Gen Psychiatry, 56, pp.749~754 (1999)
- Fagundo AB, "Modulation of irisin and physical activity on executive functions in obesity and morbid obesity", Sci Rep, 6, pp.30820~ (2016)
- Robins Wahlin TB, "Trail Making Test performance in a community-based sample of healthy very old adults : Effects of age on completion time, but not on accuracy", Arch Gerontol Geriatr, 22, pp.87~102 (1996)
- Vakil E, "Developmental changes in attention tests norms : Implications for the structure of attention", Child Neuropsychol, 15, pp.21~39 (2009)
- McCurry SM, "Neuropsychological test performance in a cognitively intact sample of older Japanese American adults", Arch Clin Neuropsychol, 16, pp.447~459 (2001)
- Cangoz B, "Trail Making Test : Normative data for Turkish elderly population by age, sex and education", J Neurol Sci, 283, pp.73~78 (2009)
- Erzin G, "Assessment of irisin levels in patients with bipolar depression and unipolar depression", Ann Clin Anal Med, 11, pp.583~586 (2020)
